FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3104621901> ?p ?o ?g. }

• W3104621901 endingPage "e21772" @default.
• W3104621901 startingPage "e21772" @default.
• W3104621901 abstract "Background Decision aids (DAs) may be used to facilitate an autonomous, informed decision to cease smoking and promote the uptake of evidence-based cessation assistance (ie, behavioral support, nicotine replacement therapy, or prescription medication). However, knowledge is lacking regarding their effective elements and (cost-)effectiveness. Objective We describe the development process of an online DA (called “VISOR”) that helps smokers to choose evidence-based cessation assistance. Additionally, we provide a description of the protocol of an ongoing randomized controlled trial in which the DA containing an explicit value clarification method (VCM) and tailored advice is compared with a DA without an explicit VCM and tailored advice. Methods The development of “VISOR” was based on the International Patient Decision Aid Standards guidelines. Viewpoints of end users (collected through 20 interviews with smokers) and clinical and scientific experts (assessed using 2 Delphi studies with 24 scientists and 38 clinicians) were assessed regarding cessation tool decision making and preferred DA content. These findings, together with principles from the Self-Determination Theory, served as input for the development of the online DA. A first DA prototype was alpha-tested in September 2019 and beta-tested for usability in December 2019; feedback was incorporated and resulted in a final version. The final DA contains (1) an information section, (2) an optional knowledge quiz, (3) a brief smoking assessment, (4) intuitive decision, (5) intermediate advice, (6) an explicit VCM, (7) tailored advice, and (8) access information. A randomized controlled trial is currently being conducted to assess the DA’s (cost-)effectiveness compared to a DA that does not include the explicit VCM and the tailored advice; specifically, the DA’s effect on smoking abstinence, uptake of evidence-based cessation assistance, smoking abstinence mediated through uptake of evidence-based cessation assistance, and decisional conflict are investigated. Participants are randomly allocated to receive access to 1 of the 2 DAs and are asked to complete 5 questionnaires (including the baseline questionnaire) over a period of 12 months. To evaluate the effects of the DA on the outcome measures, logistic and linear regression analyses as well as mediation analyses will be carried out. An economic evaluation will be performed to assess the cost-effectiveness. Results Data regarding the effect of the VISOR DA are currently being collected, and data collection is expected to be concluded in 2021. Conclusions By making use of an iterative process that integrated different stakeholders’ perspectives (including end users), we were able to systematically design an evidence-based DA. The study will contribute to the current knowledge regarding smoking cessation DA application, the added value of explicit VCMs, and the effect of behavioral and informed decision-making outcomes. Trial Registration Netherlands Trial Register NL8270; https://www.trialregister.nl/trial/8270 International Registered Report Identifier (IRRID) DERR1-10.2196/21772" @default.
• W3104621901 created "2020-11-23" @default.
• W3104621901 creator A5009477152 @default.
• W3104621901 creator A5014344831 @default.
• W3104621901 creator A5032629974 @default.
• W3104621901 creator A5048953269 @default.
• W3104621901 creator A5055643997 @default.
• W3104621901 creator A5057568983 @default.
• W3104621901 creator A5085542422 @default.
• W3104621901 date "2020-12-15" @default.
• W3104621901 modified "2023-10-03" @default.
• W3104621901 title "An Autonomy-Supportive Online Decision Aid to Assist Smokers in Choosing Evidence-Based Cessation Assistance: Development Process and Protocol of a Randomized Controlled Trial" @default.
• W3104621901 cites W1127081604 @default.
• W3104621901 cites W1859891561 @default.
• W3104621901 cites W1895840541 @default.
• W3104621901 cites W1913957972 @default.
• W3104621901 cites W1943745580 @default.
• W3104621901 cites W1955803833 @default.
• W3104621901 cites W1978258893 @default.
• W3104621901 cites W1981464567 @default.
• W3104621901 cites W2003841528 @default.
• W3104621901 cites W2006893169 @default.
• W3104621901 cites W2011294879 @default.
• W3104621901 cites W2011644590 @default.
• W3104621901 cites W2015026786 @default.
• W3104621901 cites W2034367034 @default.
• W3104621901 cites W2035627531 @default.
• W3104621901 cites W2037394322 @default.
• W3104621901 cites W2039702646 @default.
• W3104621901 cites W2048560792 @default.
• W3104621901 cites W2057806081 @default.
• W3104621901 cites W2060010505 @default.
• W3104621901 cites W2060241103 @default.
• W3104621901 cites W2072181779 @default.
• W3104621901 cites W2075004202 @default.
• W3104621901 cites W2080024546 @default.
• W3104621901 cites W2086090702 @default.
• W3104621901 cites W2087356051 @default.
• W3104621901 cites W2096764620 @default.
• W3104621901 cites W2117852129 @default.
• W3104621901 cites W2120468548 @default.
• W3104621901 cites W2145484176 @default.
• W3104621901 cites W2150427176 @default.
• W3104621901 cites W2151843199 @default.
• W3104621901 cites W2158939191 @default.
• W3104621901 cites W2159846010 @default.
• W3104621901 cites W2163058110 @default.
• W3104621901 cites W2167571049 @default.
• W3104621901 cites W2168235230 @default.
• W3104621901 cites W2180677362 @default.
• W3104621901 cites W2329193078 @default.
• W3104621901 cites W2337644055 @default.
• W3104621901 cites W2612965677 @default.
• W3104621901 cites W2704757304 @default.
• W3104621901 cites W2770636164 @default.
• W3104621901 cites W2883532803 @default.
• W3104621901 cites W2894757911 @default.
• W3104621901 cites W2916080321 @default.
• W3104621901 cites W2966350462 @default.
• W3104621901 cites W2986322108 @default.
• W3104621901 cites W3026084796 @default.
• W3104621901 cites W3212124416 @default.
• W3104621901 cites W4237719320 @default.
• W3104621901 doi "https://doi.org/10.2196/21772" @default.
• W3104621901 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7772073" @default.
• W3104621901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33320096" @default.
• W3104621901 hasPublicationYear "2020" @default.
• W3104621901 type Work @default.
• W3104621901 sameAs 3104621901 @default.
• W3104621901 citedByCount "6" @default.
• W3104621901 countsByYear W31046219012021 @default.
• W3104621901 countsByYear W31046219012022 @default.
• W3104621901 crossrefType "journal-article" @default.
• W3104621901 hasAuthorship W3104621901A5009477152 @default.
• W3104621901 hasAuthorship W3104621901A5014344831 @default.
• W3104621901 hasAuthorship W3104621901A5032629974 @default.
• W3104621901 hasAuthorship W3104621901A5048953269 @default.
• W3104621901 hasAuthorship W3104621901A5055643997 @default.
• W3104621901 hasAuthorship W3104621901A5057568983 @default.
• W3104621901 hasAuthorship W3104621901A5085542422 @default.
• W3104621901 hasBestOaLocation W31046219011 @default.
• W3104621901 hasConcept C107457646 @default.
• W3104621901 hasConcept C141071460 @default.
• W3104621901 hasConcept C142724271 @default.
• W3104621901 hasConcept C154945302 @default.
• W3104621901 hasConcept C15744967 @default.
• W3104621901 hasConcept C168563851 @default.
• W3104621901 hasConcept C170130773 @default.
• W3104621901 hasConcept C19527891 @default.
• W3104621901 hasConcept C204787440 @default.
• W3104621901 hasConcept C2777843972 @default.
• W3104621901 hasConcept C2780033181 @default.
• W3104621901 hasConcept C2780385302 @default.
• W3104621901 hasConcept C2780478649 @default.
• W3104621901 hasConcept C41008148 @default.
• W3104621901 hasConcept C509550671 @default.
• W3104621901 hasConcept C60641444 @default.
• W3104621901 hasConcept C71924100 @default.

• next